These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 28667064)

  • 41. Uremic Vascular Calcification: The Pathogenic Roles and Gastrointestinal Decontamination of Uremic Toxins.
    Chao CT; Lin SH
    Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33371477
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical studies and chronic kidney disease: what did we learn recently?
    Liabeuf S; Neirynck N; Drüeke TB; Vanholder R; Massy ZA
    Semin Nephrol; 2014 Mar; 34(2):164-79. PubMed ID: 24780471
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiorenal syndrome: the emerging role of protein-bound uremic toxins.
    Lekawanvijit S; Kompa AR; Wang BH; Kelly DJ; Krum H
    Circ Res; 2012 Nov; 111(11):1470-83. PubMed ID: 23139286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biochemical and clinical evidence for uremic toxicity.
    Bouré T; Vanholder R
    Artif Organs; 2004 Mar; 28(3):248-53. PubMed ID: 15046622
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Residual renal function: a paradigm shift.
    Lowenstein J; Grantham JJ
    Kidney Int; 2017 Mar; 91(3):561-565. PubMed ID: 28202171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Review on uremic toxins: classification, concentration, and interindividual variability.
    Vanholder R; De Smet R; Glorieux G; Argilés A; Baurmeister U; Brunet P; Clark W; Cohen G; De Deyn PP; Deppisch R; Descamps-Latscha B; Henle T; Jörres A; Lemke HD; Massy ZA; Passlick-Deetjen J; Rodriguez M; Stegmayr B; Stenvinkel P; Tetta C; Wanner C; Zidek W;
    Kidney Int; 2003 May; 63(5):1934-43. PubMed ID: 12675874
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Food-Derived Uremic Toxins in Chronic Kidney Disease.
    Lauriola M; Farré R; Evenepoel P; Overbeek SA; Meijers B
    Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828430
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Release of uremic retention solutes from protein binding by hypertonic predilution hemodiafiltration.
    Böhringer F; Jankowski V; Gajjala PR; Zidek W; Jankowski J
    ASAIO J; 2015; 61(1):55-60. PubMed ID: 25419832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome.
    Lekawanvijit S
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30200452
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Key Role for the Organic Anion Transporters, OAT1 and OAT3, in the in vivo Handling of Uremic Toxins and Solutes.
    Wu W; Bush KT; Nigam SK
    Sci Rep; 2017 Jul; 7(1):4939. PubMed ID: 28694431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New insights in uremic toxins.
    Vanholder R; Glorieux G; De Smet R; Lameire N;
    Kidney Int Suppl; 2003 May; (84):S6-10. PubMed ID: 12694297
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets.
    Lim YJ; Sidor NA; Tonial NC; Che A; Urquhart BL
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33668632
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of uremic toxin transport by organic anion transporters in the kidney.
    Deguchi T; Kusuhara H; Takadate A; Endou H; Otagiri M; Sugiyama Y
    Kidney Int; 2004 Jan; 65(1):162-74. PubMed ID: 14675047
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Uremic toxins in acute kidney injury.
    Herget-Rosenthal S; Glorieux G; Jankowski J; Jankowski V
    Semin Dial; 2009; 22(4):445-8. PubMed ID: 19708999
    [TBL] [Abstract][Full Text] [Related]  

  • 55. N-methyl-2-pyridone-5-carboxamide (2PY)-Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin.
    Lenglet A; Liabeuf S; Bodeau S; Louvet L; Mary A; Boullier A; Lemaire-Hurtel AS; Jonet A; Sonnet P; Kamel S; Massy ZA
    Toxins (Basel); 2016 Nov; 8(11):. PubMed ID: 27854278
    [No Abstract]   [Full Text] [Related]  

  • 56. Cardiorenal syndrome: role of protein-bound uremic toxins.
    Lekawanvijit S; Krum H
    J Ren Nutr; 2015 Mar; 25(2):149-54. PubMed ID: 25556308
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins.
    Brito JS; Borges NA; Esgalhado M; Magliano DC; Soulage CO; Mafra D
    Nephron; 2017; 137(1):1-7. PubMed ID: 28490014
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Uremic Toxins and their Relation to Dialysis Efficacy.
    Clark WR; Dehghani NL; Narsimhan V; Ronco C
    Blood Purif; 2019; 48(4):299-314. PubMed ID: 31563911
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport.
    Yeung CK; Shen DD; Thummel KE; Himmelfarb J
    Kidney Int; 2014 Mar; 85(3):522-8. PubMed ID: 24132209
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Accumulation of protein-bound uremic toxins: the kidney remains the leading culprit in the gut-liver-kidney axis.
    Jourde-Chiche N; Burtey S
    Kidney Int; 2020 Jun; 97(6):1102-1104. PubMed ID: 32444090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.